Saturday, Jun 20, 2026
Breaking
Search
El-Balad.com
El-Balad.com
  • Home
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World
Explore by Topics
Subscribe
El-Balad.comEl-Balad.com
Search
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World
© 2026 El-Balad.com. All Rights Reserved.
Subscribe Newsletter
  • Daily Stories
  • Stock Alerts
  • Full Access
Subscribe to our newsletter to get our newest articles instantly!

Inhibitor

Novartis Acquires PI3Kα Inhibitor to Boost Breast Cancer Treatment Pipeline
Business

Novartis Acquires PI3Kα Inhibitor to Boost Breast Cancer Treatment Pipeline

March 20, 2026
Gilead Sciences Acquires Polθ ATPase Inhibitor RP-3467 for $30 Million
Business

Gilead Sciences Acquires Polθ ATPase Inhibitor RP-3467 for $30 Million

December 24, 2025
Merck’s Oral PCSK9 Inhibitor Cuts LDL-C in Phase 3 Trial
Business

Merck’s Oral PCSK9 Inhibitor Cuts LDL-C in Phase 3 Trial

November 9, 2025

The Daily Newsletter

Brings you a selection of the latest news, trends, insights, and tips from around the world.
El-Balad.com
El-Balad.com is your trusted source for comprehensive and balanced news coverage. With a commitment to integrity and accuracy, we provide in-depth reporting that uncovers the stories that matter most.
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World

More Links

  • About
  • Contact
  • Privacy